Annual Report 2021

1.   Journal summary from Editor in Chief

Together with the Editorial Office of AIMS Allergy and Immunology, I wish to testify my sincere gratitude to all authors, members of the editorial board and reviewers, thanking everyone for their contribution to AIMS Allergy and Immunology in 2021.

It was the support of all members of our editorial board and peer reviewers that, despite of COVID-19 difficulties, made possible to successfully complete the full peer review, editing and publishing processes for AIMS Allergy and Immunology in 2021.

The submissions of our AIMS Allergy and Immunology journal in 2021 increased significantly, with 4 papers under processing (submitted in 2021); during this 2021 we had 50% acceptance/rejection ratio and publication time (from submission to online) was reduced from 70.4 days to 61 days, illustrating the strict and efficient review process. We have 10 top articles with highest citations from 5 (1 paper), 4 (3 papers), 3 (2 papers), 2 (4 papers), and many countries are represented among our authors.

An important part of our strategy has been preparation of special issues. In 2021, two special issues and four topical sections were planned. AIMS Allergy and Immunology has 67 members now, and 8 of which joined in 2021. We will continue to renew editorial board in 2022.

To promote and encourage submissions we have established the “Best Paper Award” and “Editorial board member of the year” for the editorial board member who introduced the largest number of researchers, authors of manuscripts accepted/published or in press.

The road is still long and winding but we hope that in 2022, with the support of all the members of the editorial board and reviewers, it will be possible to expand the number of papers submitted and accepted, to be able to publish the scientific contributions of the congresses and special issues organized by the members of the editorial board, to increase the citation/paper and total citations to get the academic rank of AIMS Allergy and Immunology as soon as possible.

Prof. Marcella Reale, Editor-in-Chief

AIMS Allergy and Immunology journal

Dept. of Innovative Technologies in Medicine and Dentistry

University “G. d'Annunzio” Chieti-Pescara

Via dei Vestini, Chieti, Italy

2.   Editorial development

2.1.   Manuscripts statistics

Under processing paper: 4

Rejection rate: 50%

Publication time (from submission to online): 61 days

2.2.   Author distribution

2.3.   Articles type

2.4.   Articles metrics

The top 10 articles with highest viewed:

The top 10 articles with highest citations:

2.5.   Topical section/special issue with the most papers

Topical section

Immunity to Viruses

https://www.aimspress.com/allergy/article/5830/special-articles

Special issue

The role of extracellular vesicles and miRNAs in allergy and immune tolerance

Special issue editor: Dr. Katarzyna Nazimek

https://www.aimspress.com/allergy/article/5855/special-articles

2.6.   Editorial board members

AIMS Allergy and Immunology has 67 members, and 8 of which joined in 2021.

2.7.   Summary & plan

2.7.1.   Summary

In the fifth year of our journal, the journal developed much faster than before under the leadership of the Editor-in-Chief Prof. Marcella Reale. We have received 36 submissions and published 20 papers in 2021.

We reduce the publication time from 70.4 days to 61 days. Each submitted article is processed carefully, fairly, promptly, and the accepted papers appear in the journal in the shortest time.

2.7.2.   Plan in 2022

Increase influence by soliciting and advertising high quality articles and special issues (topics).

We seek to be indexed by more databases in 2022.